Conmed (CNMD) Cost of Revenue (2016 - 2020)
Historic Cost of Revenue for Conmed (CNMD) over the last 11 years, with Q4 2020 value amounting to $117.3 million.
- Conmed's Cost of Revenue fell 453.74% to $117.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was $402.2 million, marking a year-over-year decrease of 655.79%. This contributed to the annual value of $624.2 million for FY2025, which is 875.74% up from last year.
- Per Conmed's latest filing, its Cost of Revenue stood at $117.3 million for Q4 2020, which was down 453.74% from $104.1 million recorded in Q3 2020.
- Over the past 5 years, Conmed's Cost of Revenue peaked at $122.9 million during Q4 2019, and registered a low of $83.5 million during Q1 2016.
- For the 5-year period, Conmed's Cost of Revenue averaged around $97.2 million, with its median value being $95.7 million (2018).
- As far as peak fluctuations go, Conmed's Cost of Revenue skyrocketed by 1286.98% in 2019, and later crashed by 1981.55% in 2020.
- Conmed's Cost of Revenue (Quarter) stood at $97.1 million in 2016, then rose by 1.51% to $98.6 million in 2017, then increased by 11.35% to $109.8 million in 2018, then grew by 11.93% to $122.9 million in 2019, then dropped by 4.54% to $117.3 million in 2020.
- Its Cost of Revenue stands at $117.3 million for Q4 2020, versus $104.1 million for Q3 2020 and $85.9 million for Q2 2020.